Index of reports
> Cases with Pulmonary Oedema (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Nafcillin where reactions include pulmonary oedema. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Nafcillin side effects in 31 year old female
Reported by a physician from United States on 2012-08-24
Patient: 31 year old female
Reactions: Coagulopathy, Disseminated Intravascular Coagulation, Pyrexia, Pulmonary Oedema, Endocarditis, Hypoxia, Epistaxis, Right Ventricular Failure, Mechanical Ventilation, Metabolic Acidosis, Pneumonia, Hypotension, Pulmonary Arterial Wedge Pressure Increased, Myopathy, Bacteraemia, Subarachnoid Haemorrhage, Haemorrhage, Pulmonary Arterial Hypertension, Adrenal Insufficiency, Abdominal Distension, Ischaemic Hepatitis, Thrombocytopenia, Fluid Overload, Device Related Sepsis, Dyspnoea, Atrial Flutter, Condition Aggravated, Rash, Subdural Haemorrhage, Cardiogenic Shock, Blood Glucose Decreased, Renal Failure, Respiratory Failure, Respiratory Acidosis, Ventricular Fibrillation
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Epoprostenol Sodium
Dosage: 30 ng/kg, per min
Start date: 2010-10-19
End date: 2012-01-01
Epoprostenol Sodium
Dosage: 33 ng/kg, per min
Indication: Pulmonary Arterial Hypertension
Start date: 2012-01-01
End date: 2012-06-17
Nafcillin
Tracleer
Dosage: unk
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2008-04-08
Other drugs received by patient: Remeron; Digoxin; Ferrous Sulfate TAB; Revatio; Zantac; Potassium Chloride; Hibiclens; Coumadin; Spironolactone; Celexa; Zofran; Furosemide; Oxycodone HCL; Oxygen
Possible Nafcillin side effects in
Reported by a consumer/non-health professional from United States on 2012-07-12
Patient:
Reactions: Pulmonary Hypertension, Haemorrhage, Coagulopathy, Pyrexia, Pulmonary Oedema, Hypoxia, Adrenal Insufficiency, Abdominal Distension, Endocarditis, Ischaemic Hepatitis, Thrombocytopenia, Epistaxis, Fluid Overload, Device Related Sepsis, Right Ventricular Failure, Mechanical Ventilation, Dyspnoea, Pneumonia, Metabolic Acidosis, Atrial Flutter, Rash, Pulmonary Arterial Wedge Pressure Increased, Cardiogenic Shock, Subdural Haemorrhage, Myopathy, Blood Glucose Decreased, Renal Failure, Respiratory Acidosis, Respiratory Failure, Bacteraemia, Subarachnoid Haemorrhage, Ventricular Fibrillation
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Tracleer
Dosage: unk
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2008-04-08
Epoprostenol Sodium
Dosage: 33 ng/kg, per min
Indication: Pulmonary Arterial Hypertension
Start date: 2012-01-01
End date: 2012-06-17
Epoprostenol Sodium
Dosage: 30 ng/kg, per min
Start date: 2010-10-19
End date: 2012-01-01
Nafcillin
Other drugs received by patient: Furosemide; Potassium Chloride; Oxycodone HCL; Celexa; Remeron; Coumadin; Digoxin; Hibiclens; Zofran; Zantac; Ferrous Sulfate TAB; Revatio; Spironolactone; Oxygen
Possible Nafcillin side effects in
Reported by a pharmacist from United States on 2012-07-02
Patient:
Reactions: Pulmonary Hypertension, Haemorrhage, Coagulopathy, Pyrexia, Endocarditis, Hypoxia, Abdominal Distension, Pulmonary Oedema, Adrenal Insufficiency, Ischaemic Hepatitis, Thrombocytopenia, Epistaxis, Mechanical Ventilation, Fluid Overload, Right Ventricular Failure, Pneumonia, Metabolic Acidosis, Dyspnoea, Atrial Flutter, Pulmonary Arterial Wedge Pressure Increased, Rash, Cardiogenic Shock, Subdural Haemorrhage, Myopathy, Blood Glucose Decreased, Renal Failure, Subarachnoid Haemorrhage, Respiratory Failure, Respiratory Acidosis, Bacteraemia, Ventricular Fibrillation
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Epoprostenol Sodium
Dosage: 33 ng/kg, per min
Start date: 2012-01-01
End date: 2012-06-17
Tracleer
Dosage: unk
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2008-04-08
Nafcillin
Epoprostenol Sodium
Dosage: 30 ng/kg, per min
Indication: Pulmonary Arterial Hypertension
Start date: 2010-10-19
End date: 2012-01-01
Other drugs received by patient: Remeron; Spironolactone; Hibiclens; Oxygen; Revatio; Oxycodone HCL; Zantac; Furosemide; Ferrous Sulfate TAB; Digoxin; Zofran; Celexa; Coumadin; Potassium Chloride
Possible Nafcillin side effects in
Reported by a pharmacist from United States on 2012-06-14
Patient:
Reactions: Pulmonary Hypertension, Fluid Overload, Dyspnoea, Pneumonia, Atrial Flutter, Rash, Pyrexia, Pulmonary Arterial Wedge Pressure Increased, Cardiac Output Decreased, Bacteraemia, Hypoxia, Endocarditis, Pulmonary Oedema, Abdominal Distension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epoprostenol Sodium
Dosage: 30 ng/kg, per min
Indication: Pulmonary Arterial Hypertension
Start date: 2010-10-19
End date: 2012-01-01
Nafcillin
Epoprostenol Sodium
Dosage: 33 ng/kg, per min
Start date: 2012-01-01
Other drugs received by patient: Tracleer; Remeron; Digoxin; Zantac; Spironolactone; Hibiclens; Zofran; Ferrous Sulfate TAB; Coumadin; Revatio; Oxycodone HCL; Furosemide; Celexa; Potassium Chloride; Oxygen
|